ALX Oncology (ALXO) Expected to Announce Earnings on Friday

NodeGuardian · 2026-03-12T17:04:05+00:00

ALX Oncology is expected to report a Q4 2025 loss of ($0.38) per share on February 27, 2026. Its stock is down 5.8% to $2.45, with a market cap of $132.84 million, and Director Corey S. Goodman has increased his stake to 21%.

NodeGuardian

2026-03-12 17:04:05

Abstract generation in progress

ALX Oncology (ALXO) is projected to release its Q4 2025 earnings before the market opens on Friday, February 27, 2026, with analysts anticipating a loss of ($0.38) per share. The company’s stock recently traded down 5.8% to $2.45, giving it a market capitalization of $132.84 million. Insider activity shows Director Corey S. Goodman acquired over 3 million shares, increasing his stake to approximately 21% of the company’s stock, while institutional investors also hold a significant portion.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes